Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor update to the page version and likely routine fixes or tweaks.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a deployment of the front-end platform; this appears to be an internal update rather than a change to study details or eligibility information.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page. This indicates a minor site update without changes to the study content.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing the previous Revision: v3.6.2. This reflects a version update to the page's metadata.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision v3.6.2 was added. The previous revision v3.6.0 was removed.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page now indicates no longer looking for participants and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label formatting is adjusted and the site revision is updated to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.